Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 evolution during treatment of chronic infection
Steven A. Kemp, Dami A. Collier, Rawlings Datir, et al.
Nature (2021) Vol. 592, Iss. 7853, pp. 277-282
Open Access | Times Cited: 984

Showing 1-25 of 984 citing articles:

SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey, Alessandro M. Carabelli, Ben Jackson, et al.
Nature Reviews Microbiology (2021) Vol. 19, Iss. 7, pp. 409-424
Open Access | Times Cited: 3370
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies, Sam Abbott, Rosanna C. Barnard, et al.
Science (2021) Vol. 372, Iss. 6538
Open Access | Times Cited: 2450
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang, Manoj S. Nair, Lihong Liu, et al.
Nature (2021) Vol. 593, Iss. 7857, pp. 130-135
Open Access | Times Cited: 2239
Detection of a SARS-CoV-2 variant of concern in South Africa
Houriiyah Tegally, Eduan Wilkinson, Marta Giovanetti, et al.
Nature (2021) Vol. 592, Iss. 7854, pp. 438-443
Open Access | Times Cited: 1674
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar, et al.
Nature (2021) Vol. 599, Iss. 7883, pp. 114-119
Open Access | Times Cited: 1279
Infectious disease in an era of global change
Rachel E. Baker, Ayesha S. Mahmud, Ian F. Miller, et al.
Nature Reviews Microbiology (2021) Vol. 20, Iss. 4, pp. 193-205
Open Access | Times Cited: 1167
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Daming Zhou, Wanwisa Dejnirattisai, Piyada Supasa, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2348-2361.e6
Open Access | Times Cited: 1099
The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 937
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Wanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
Cell (2022) Vol. 185, Iss. 3, pp. 467-484.e15
Open Access | Times Cited: 921
Vaccine Breakthrough Infections with SARS-CoV-2 Variants
Ezgi Hacisuleyman, Caryn Hale, Yuhki Saito, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 23, pp. 2212-2218
Open Access | Times Cited: 744
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas, Timothée Bruel, Ludivine Grzelak, et al.
Nature Medicine (2021) Vol. 27, Iss. 5, pp. 917-924
Closed Access | Times Cited: 732
Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
Amy D. Proal, Michael B. VanElzakker
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 729
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Chang Liu, Helen M. Ginn, Wanwisa Dejnirattisai, et al.
Cell (2021) Vol. 184, Iss. 16, pp. 4220-4236.e13
Open Access | Times Cited: 708
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Dami A. Collier, Anna De Marco, Isabella A. T. M. Ferreira, et al.
Nature (2021) Vol. 593, Iss. 7857, pp. 136-141
Open Access | Times Cited: 692
The immunology and immunopathology of COVID-19
Miriam Mérad, Catherine A. Blish, Federica Sallusto, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1122-1127
Open Access | Times Cited: 677
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Dami A. Collier, Isabella A. T. M. Ferreira, Prasanti Kotagiri, et al.
Nature (2021) Vol. 596, Iss. 7872, pp. 417-422
Open Access | Times Cited: 668
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Aekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2422-2433.e13
Open Access | Times Cited: 668
Antibody evasion by the P.1 strain of SARS-CoV-2
Wanwisa Dejnirattisai, Daming Zhou, Piyada Supasa, et al.
Cell (2021) Vol. 184, Iss. 11, pp. 2939-2954.e9
Open Access | Times Cited: 616
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 6, pp. 765-778
Open Access | Times Cited: 578
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
Xianding Deng, Miguel Garcia-Knight, Mir M. Khalid, et al.
Cell (2021) Vol. 184, Iss. 13, pp. 3426-3437.e8
Open Access | Times Cited: 513
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study
Dan Frampton, Tommy Rampling, Aidan Cross, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 9, pp. 1246-1256
Open Access | Times Cited: 443
The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant
Dandan Tian, Yanhong Sun, Huihong Xu, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2376-2383
Open Access | Times Cited: 428
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Bo Meng, Steven A. Kemp, Guido Papa, et al.
Cell Reports (2021) Vol. 35, Iss. 13, pp. 109292-109292
Open Access | Times Cited: 412
SARS-CoV-2 Variants in Patients with Immunosuppression
Lawrence Corey, Chris Beyrer, Myron S. Cohen, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 6, pp. 562-566
Open Access | Times Cited: 410
Page 1 - Next Page

Scroll to top